We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.2%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$16.9B
AUM Growth
-$468M
(-2.7%)
Cap. Flow
+$68M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
1,101
New
144
Increased
331
Reduced
453
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$319M |
| 2 |
Uber
UBER
|
+$90.8M |
| 3 |
Tyson Foods
TSN
|
+$81.8M |
| 4 |
Archer Daniels Midland
ADM
|
+$81.5M |
| 5 |
Travelers Companies
TRV
|
+$81.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$106M |
| 2 |
Lockheed Martin
LMT
|
+$88.6M |
| 3 |
Ross Stores
ROST
|
+$77.9M |
| 4 |
Hilton Worldwide
HLT
|
+$69.3M |
| 5 |
Cigna
CI
|
+$58.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.51% |
| 2 | Financials | 12.87% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 12.35% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
American Realty Investors
ARL
$241M
| $198K | ﹤0.01% |
13,560
-211
| -2% | -$3.97K |
|
|
EGRX
927
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $183K | ﹤0.01% |
+11,586
| New | +$208K |
|
|
MCBC
928
DELISTED
Macatawa Bank Corp
MCBC
| $173K | ﹤0.01% |
19,255
-26
| -0.1% | -$243 |
|
929
Mistras Group
MG
$490M
| $166K | ﹤0.01% |
30,473
+8,575
| +39% | +$53.8K |
|
|
ZYXI
930
DELISTED
Zynex
ZYXI
| $164K | ﹤0.01% |
+20,552
| New | +$172K |
|
|
FIRY
931
Firy Inc
FIRY
$154M
| $152K | ﹤0.01% |
29,863
-67,111
| -69% | -$596K |
|
932
Quantum Corp
QMCO
$444M
| $152K | ﹤0.01% |
12,468
+2,158
| +21% | +$35.7K |
|
933
American Outdoor Brands
AOUT
$159M
| $152K | ﹤0.01% |
15,550
-22
| -0.1% | -$205 |
|
|
OMIC
934
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $137K | ﹤0.01% |
11,956
+5,103
| +74% | +$94.8K |
|
935
Shattuck Labs
STTK
$651M
| $114K | ﹤0.01% |
75,113
-18,218
| -20% | -$41.6K |
|
936
Investar Holding Corp
ISTR
$415M
| $106K | ﹤0.01% |
10,036
-92
| -0.9% | -$1.18K |
|
937
MediaAlpha
MAX
$746M
| $103K | ﹤0.01% |
12,473
-38,047
| -75% | -$340K |
|
938
Ranpak Holdings
PACK
$550M
| $103K | ﹤0.01% |
18,871
-185,799
| -91% | -$1.02M |
|
|
SHCR
939
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $101K | ﹤0.01% |
+106,900
| New | +$128K |
|
940
Matinas BioPharma
MTNB
$1.88M
| $98.1K | ﹤0.01% |
+15,095
| New | +$185K |
|
941
KVH Industries
KVHI
$172M
| $96.4K | ﹤0.01% |
18,897
-58
| -0.3% | -$393 |
|
|
TRTX
942
TPG RE Finance Trust
TRTX
$660M
| $96.1K | ﹤0.01% |
+14,282
| New | +$103K |
|
943
Cardiff Oncology
CRDF
$63.6M
| $91.1K | ﹤0.01% |
65,558
-31,495
| -32% | -$53.1K |
|
944
CarParts.com
PRTS
$42.4M
| $85.4K | ﹤0.01% |
2,073
+68
| +3% | +$3.01K |
|
945
Verastem
VSTM
$547M
| $82.1K | ﹤0.01% |
10,103
| – | – |
|
|
ALLK
946
DELISTED
Allakos
ALLK
| $69.9K | ﹤0.01% |
30,811
-134,463
| -81% | -$499K |
|
|
AEVA
947
Aeva Technologies
AEVA
$1B
| $66.4K | ﹤0.01% |
+17,365
| New | +$91.8K |
|
|
KRON
948
DELISTED
Kronos Bio
KRON
| $66.1K | ﹤0.01% |
50,814
-4,451
| -8% | -$7.19K |
|
|
CPTN
949
DELISTED
Cepton, Inc. Common Stock
CPTN
| $53.7K | ﹤0.01% |
+14,137
| New | +$82.2K |
|
950
Cartesian Therapeutics
RNAC
$225M
| $34.4K | ﹤0.01% |
1,083
-12,694
| -92% | -$424K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2023 Portfolio in Review
As of Q3 2023, Jacobs Levy Equity Management held 1,101 positions worth $16.9B, down 2.7% from $17.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management's Q3 2023 filing shows 144 new, 331 increased, 453 reduced and 149 closed positions. Its largest new stake was Tyson Foods: 1,536,421 shares worth $77.6M. The largest sale was Altria Group, an estimated $106M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q3 2023 buy was Tyson Foods: 1,536,421 shares worth $77.6M.
- Jacobs Levy Equity Management added most to NVIDIA in Q3 2023, an estimated $319M increase.
- Jacobs Levy Equity Management's biggest Q3 2023 reduction was Altria Group, cutting an estimated $106M.
- Jacobs Levy Equity Management fully exited Hilton Worldwide in Q3 2023, selling an estimated $69.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $16.9B portfolio in Q3 2023.
- Jacobs Levy Equity Management opened 144 new positions and closed 149 in Q3 2023.
- Jacobs Levy Equity Management's portfolio value fell 2.7% quarter-over-quarter to $16.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.